Baurain, J;
Awada, A;
Brunsvig, P;
Kristeleit, RS;
Loirat, D;
Jossang, D;
Zitvogel, L;
... Spicer, J; + view all
(2017)
A phase I dose escalation study of intra-tumoral LTX-315 as monotherapy or in combination with either ipilimumab or pembrolizumab in patients with transdermally accessible tumors (NCT01986426).
Presented at: AACR Annual Meeting 2017, Washington, D.C., USA.
Preview |
Text
Kristeleit_A phase I dose escalation study of intra.pdf Download (221kB) | Preview |
Type: | Conference item (Presentation) |
---|---|
Title: | A phase I dose escalation study of intra-tumoral LTX-315 as monotherapy or in combination with either ipilimumab or pembrolizumab in patients with transdermally accessible tumors (NCT01986426) |
Event: | AACR Annual Meeting 2017 |
Location: | Washington, D.C., USA |
Dates: | 01 - 05 April 2017 |
Open access status: | An open access version is available from UCL Discovery |
Publisher version: | https://doi.org/10.1158/1538-7445.AM2017-CT108 |
Language: | English |
Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
UCL classification: | UCL UCL > Provost and Vice Provost Offices UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Oncology |
URI: | https://discovery.ucl.ac.uk/id/eprint/1553485 |
Archive Staff Only
View Item |